MicroPort CardioFlow Medtech Corporation (MP CardioFlow-B) reported no changes to either its authorised or issued share capital for July 2026.

Authorised / Registered Capital • The company’s authorised share capital remained at 2.00 billion ordinary shares with a par value of USD 0.000025 each, equivalent to USD 50,000 in total.

Issued Shares and Public Float • Issued shares (excluding treasury shares) were unchanged at 1.27 billion. • There were no treasury shares outstanding, and the listed entity confirmed compliance with Hong Kong’s 25% minimum public-float requirement.

Share Option Movements • Under the 2020 share option scheme, 20,000 options were cancelled, leaving 10.53 million options outstanding at month-end. No options were exercised. • Under the 2023 share scheme, 18,572 options were cancelled and 440,000 new options were granted, raising the outstanding balance to 5.24 million. • No new shares were issued and no treasury shares were transferred as a result of option exercises during the month, generating zero proceeds.

Other Securities • The company reported no activity in warrants, convertible securities, or other share issuance arrangements.

Overall, MP CardioFlow-B maintained a stable capital structure through July 2026, with only minor administrative adjustments to its outstanding share-based incentives and no impact on the total share count.